APOLIPOPROTEIN A-I - ANVISA Registration 82444370073
Access comprehensive regulatory information for APOLIPOPROTEIN A-I in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370073 and manufactured by DIAZYME LABORATORIES, INC.. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORTHO CLINICAL DIAGNÓSTICS , INC., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
82444370073
25351634712202372
07214566000165
Company Information
Dates and Status
Oct 30, 2023
VIGENTE
09/18/2025 19:00:01
ORTHO CLINICAL DIAGNÓSTICS , INC.• United States of America
ROCHE DIAGNOSTICS GMBH• Germany
SIEMENS HEALTHCARE DIAGNOSTICS INC.• United States of America
LABORLAB PRODUTOS PARA LABORATÓRIOS LTDA EPP• Brazil
DIASYS DIAGNOSTIC SYSTEMS GMBH & CO.• Germany
APOLIPOPROTEÍNA A-I
Apoliproteína A1
DIAGAM S.A.
81546350080
Jan 06, 2025
APOLIPOPROTEÍNA A-I
Apo A1 Turbiquest
LABTEST DIAGNOSTICA S/A
10009010458
Aug 05, 2024
APOLIPOPROTEÍNA A-I
FAMÍLIA DE REAGENTE, CALIBRADOR E CONTROLES Optilite® Apolipoprotein A-1
THE BINDING SITE GROUP LTD
81357320129
Jun 05, 2023
APOLIPOPROTEÍNA A-I
Apolipoprotein A1
THERMO FISHER SCIENTIFIC OY
80254180416
Apr 28, 2022
APOLIPOPROTEÍNA A-I
APOAT (Tina-quant Apolipoprotein A-1 ver.2)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411393
Jul 01, 2019

